Panel Discussion: Streamlining CDx Development for Improved Precision Therapies
Time: 2:55 pm
day: Conference Day 1 PM
Details:
- Key considerations for genomic testing in clinical trials in APAC while targeting FDA submissions
- Strategies to use China clinical trial data in global CDx submissions
- The potential impacts the Biosecure act could have in choosing your CDx or testing partner in China
- Improving awareness of Liquid Biopsy in APAC. How can we work together for better options for patients
